Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Professor John Staffurth is a Consultant Clinical Oncologist specialising in urological oncology. His clinical base is at Velindre Cancer Centre and the University Hospital of Wales and his academic base is at Cardiff University where he is Reader in Oncology in Professor Malcolm Mason’s research group.
He trained at Guy's Hospital, qualified in 1992 and started clinical oncology training in 1996. He moved to the Royal Marsden in 1999 and joined the Academic Urology Unit in 2000 taking an MD in IMRT in Pelvic Malignancies at the Institute of Cancer Research.
Professor Staffurth's current research interests are technical radiotherapy for bladder and prostate cancer, and all other aspects of prostate cancer, specifically management of castrate refractory disease states and the immunology of prostate cancer. He leads the introduction of both IMRT and IGRT at Velindre Cancer Centre.
Proton Beam Therapy
This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.